Suchergebnisse - "Baecklund, Eva"

PubPharm (132)

31

Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype

enthalten in: Rheumatology (Oxford, England) | 2021

von Hellgren, K. | Di Giuseppe, D. | Smedby, K. | +4

32

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

enthalten in: Rheumatology (Oxford, England) | 2021

von Thorlacius, G. | Hultin-Rosenberg, L. | Sandling, J. | +87

33

Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

enthalten in: Pharmacogenomics | 2021

von Sundbaum, J. | Baecklund, E. | Eriksson, N. | +6

34

Superior outcome for splenectomised patients in a population‐based study of splenic marginal zone lymphoma in Sweden

enthalten in: British Journal of Haematology | 2021

von Sima, A. | Hollander, P. | Baecklund, E. | +3

35

Patient preferences on rheumatoid arthritis second-line treatment : a discrete choice experiment of Swedish patients

enthalten in: Arthritis research & therapy | 2020

von Bywall, K. | Kihlbom, U. | Hansson, M. | +4

36

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

enthalten in: Arthritis Research & Therapy | 2020

von Bywall, K. | Kihlbom, U. | Hansson, M. | +4

37

Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial

enthalten in: BMJ (Clinical research ed.) | 2020

von Hetland, M. | Haavardsholm, E. | Rudin, A. | +96

38

Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial

Erschienen: 2020

von Hetland, M. | Haavardsholm, E. | Rudin, A. | +40

39

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

enthalten in: Pharmacogenomics | 2020

von Sundbaum, J. | Baecklund, E. | Eriksson, N. | +3

40

Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

enthalten in: Annals of the rheumatic diseases | 2020

von Mofors, J. | Björk, A. | Smedby, K. | +8